Robots wielding ‘click chemistry’ pinpoint metal substances as promising novel antibiotics.

“`html

A stimulating antibiotic ingredient was discovered by scientists, and it incorporates the element iridium (shown in the image above).(Image credit: RHJ/Getty Images)ShareShare by:

  • Copy link
  • Facebook
  • X
  • Whatsapp
  • Reddit
  • Flipboard

Share this article 0Join the conversationFollow usAdd us as a preferred source on GoogleNewsletterSubscribe to our newsletter

According to a recent study, a metal complex of iridium has been recognized as a hopeful, albeit unique, new antibiotic medicine.

The compound represents one of over 600 generated in a piece of research released in December in the journal Nature Communications. The researchers employed a robot to produce the compounds, blending metal and organic molecule components to construct a vast chemical repository in only one week.

Given the rising incidence of drug-resistant bacterial illnesses, there exists a demand for novel, potent antibiotics capable of eliminating microbes that are no longer susceptible to current treatments. Up until now, explorations have largely been geared toward organic — that is, carbon-based — molecules, with metal complexes being nearly completely ignored.

These metal-inclusive substances exhibit remarkably varied configurations when juxtaposed with their less dimensional organic counterparts, and their three-dimensional forms lead to distinctive chemical and biological traits. Coupled with their straightforward synthesis, this quality positions these molecules as an exciting source of potential antibiotics in the times ahead, state the study’s authors.

Nonetheless, considering the limited existing information regarding the antimicrobial characteristics of metal complexes, Frei’s group required an effective technique to swiftly fabricate and evaluate a substantial number of compounds. Their answer was to fuse uncomplicated and dependable chemistry with cutting-edge automation.

The group started by assembling a compilation of 192 unique ligands, the organic molecules responsible for binding to the metal center and dictating the complex’s eventual attributes. They accomplished this by utilizing a liquid-handling robot to conduct “click chemistry.” This robust reaction unites two categories of starting materials — termed azides and alkynes — to construct nitrogen-comprising rings recognized as triazoles. These nitrogen rings form strong bonds with metals.

In the subsequent phase of the process, the robot integrated each of the 192 ligands alongside five distinct metals, yielding a collective of 672 metal complexes.

“We chose to harness liquid-handling robots for the chemistry due to the fact that it simply involves combining various reagents in the correct ratios,” Frei mentioned. After generating the azides, “we then introduced the alkynes and the catalyst to facilitate the click reaction, and subsequently applied those ligands to different metals. All of this can be executed in a single container with robots,” he elaborated.

Each manufactured item underwent analysis to ascertain the predicted complex had materialized and was then promptly assessed for antibacterial capabilities and prospective toxicity to human cells. In this manner, the group promptly pinpointed the safest and most powerful substances, sidestepping the need to spend time on protracted purification measures.

“It enables us to transition from several hundred compounds to perhaps a few dozen compounds that hold promise,” Frei clarified.

Complexes harboring iridium and rhenium manifested notably elevated degrees of antibacterial efficacy. By and large, 59 of the iridium substances and 61 of the rhenium substances impeded the proliferation of Staphylococcus aureus, a prominent instigator of hospital-related infections that can span from moderate to grave. For both metals, the toxicity toward human cells showed variability. From this preliminary screening data, the group handpicked the six substances that best harmonized antibacterial effectiveness with reduced toxicity for auxiliary research.

“Upon identifying those particularly encouraging substances, we can then revisit the bench and recreate them, isolate them, and characterize them, to affirm what we previously observed with the [unpurified] blend,” Frei stated.

In this ensuing cycle of tests, a particular iridium complex clearly distinguished itself as the most exceptional. The substance showcased approximately 50 to 100 times enhanced activity against bacteria in comparison to its toxicity to human cells. This substantial disparity assumes critical importance in ensuring that the complex is simultaneously efficacious in managing an infection while also remaining safe for application on human tissues.

Mark Blaskovich, a molecular bioscientist at the University of Queensland in Australia who had no participation in the endeavor, expressed his admiration for the efficiency of Frei’s methodology and the heterogeneity of the substances spawned by the automated synthesis. Nonetheless, a notable volume of work remains essential in transforming their antibiotic contenders into practical clinical medications, he asserted.

He indicated in an email to Live Science that the “most crucial next steps” involve demonstrating that the most assuring substances possess drug-like characteristics, implying that they exhibit chemical stability and circumvent extensive off-target impacts on the body. Furthermore, research must corroborate the operational mechanism of these substances within a living body, “ideally employing the ‘gold standard’ mouse models of infection,” he conveyed.

RELATED STORIES

—Antibiotic identified in plain sight may treat dangerous infections, initial study suggests

—Hazardous ‘superbugs’ constitute a mounting hazard, and antibiotics are unable to halt their progress. What countermeasures exist?

—Antibiotics progressively ineffectual for ailments of childhood

In order for these prospective antibiotics to secure authorization for clinical implementation, studies involving lab animals would ultimately be succeeded by clinical assessments capable of decisively demonstrating the drugs’ simultaneous safety and efficacy for individuals.

For the moment, however, Frei has intentions to elaborate upon this preliminary assortment of substances, leveraging artificial intelligence to aid in targeting specific attributes.

“We can employ this information to facilitate savvier decision-making,” he communicated. “Accordingly, we can undertake machine learning and educate models to correlate which structural traits translate to heightened activity and diminished toxicity and then task the model with forecasting which substances we ought to fabricate next.”

Victoria AtkinsonSocial Links NavigationLive Science Contributor

Victoria Atkinson functions as an independent science journalist, specializing in chemistry and its confluence with both the natural and artificial spheres. Presently stationed in York (UK), she formerly served as a science content architect at the University of Oxford, and subsequently as a contributor to the Chemistry World editorial division. Since embracing the role of a freelancer, Victoria has amplified her concentration to delve into subjects spanning diverse scientific domains and has collaborated with Chemistry Review, Neon Squid Publishing, and the Open University, among others. She possesses a DPhil in organic chemistry from the University of Oxford.

Show More Comments

You must confirm your public display name before commenting

Please logout and then login again, you will then be prompted to enter your display name.

LogoutLatest in Medicine & Drugs

US government overhauls the childhood vaccine schedule in unprecedented move 
 

New drug could prevent diabetes complications not fixed with blood sugar control, study hints 
 

New antivenom works against 17 dangerous African snake species, study suggests 
 

Newfound antibiotic shows ‘100 times’ more potency against drug-resistant bacteria than its predecessor 
 

One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it 
 

‘This is a completely different level of anti-vaccine engagement than we’ve ever seen before,’ says epidemiologist Dr. Seth Berkley 
 Latest in News

Metal compounds identified as potential new antibiotics, thanks to robots doing ‘click chemistry’ 
 

Astronomers may have already spotted the ‘Great Comet of 2026’ — and it could soon be visible to the naked eye 
 

Oddball ‘platypus galaxies’ spotted by James Webb telescope may challenge our understanding of galaxy formation 
 

Monumental tomb discovered in Turkey might be of royal from King Midas’ kingdom 
 

Dionysus and his erect penis depicted on 2,500-year-old bone stylus found in Sicily 
 

China’s ‘artificial sun’ reactor shatters major fusion limit — a step closer to near-limitless clean energy 
 LATEST ARTICLES

  • Leave a Reply

    Your email address will not be published. Required fields are marked *